feed,title,long_url,short_url
Investors,Prometheus Biosciences Stock Shows Rising Relative Strength,https://www.investors.com/news/technology/prometheus-biosciences-stock-shows-rising-relative-strength/,https://bit.ly/3aBiSnv
Investors,Merus Stock Joins Rank Of Stocks With RS Ratings Over 90,https://www.investors.com/news/technology/merus-stock-joins-rank-of-stocks-with-rs-ratings-over-90/,https://bit.ly/3RDgygb
Investors,Novavax Tanks On New Troubles For Its Newly Authorized Covid Vaccine,https://www.investors.com/news/technology/nvax-stock-novavax-wins-fda-nod-for-covid-vaccine/,https://bit.ly/3APSoJG
Investors,"Google Stock Split Coming Soon As Amazon, Shopify Lack Boost",https://www.investors.com/news/technology/googl-stock-split-due-late-friday-as-amazon-shopify-search-for-split-boost/,https://bit.ly/3yVaWGL
Investors,Wall Street Criticizes Netflix's Choice Of Microsoft As Advertising Partner,https://www.investors.com/news/technology/netflix-stock-video-streamer-picks-microsoft-as-ad-partner/,https://bit.ly/3ASWTD8
Investors,"Taiwan Semiconductor Tops Second-Quarter Targets, Guides Higher",https://www.investors.com/news/technology/tsm-stock-taiwan-semiconductor-tops-q2-targets-guides-higher/,https://bit.ly/3IG8N5l
Investors,Why Tech Stocks May Be The Wrong Play If A Recession Hits,https://www.investors.com/news/technology/tech-stocks-not-as-defensive-as-hoped-if-recession-hits-says-bofa/,https://bit.ly/3ID9YSV
Investors,"FANG Stocks News & Quotes: Facebook, Amazon, Netflix, Google",https://www.investors.com/news/technology/fang-stocks-news-quotes-meta-facebook-amazon-netflix-google/,https://bit.ly/3nOmplo
Investors,Why Telecom Stocks Are Outperforming S&P 500 As Recession Looms,https://www.investors.com/news/technology/vz-stock-t-stock-tmus-stock-outperforming-sp-500/,https://bit.ly/3ICSaaD
Investors,Siga Technologies Extends Its Monkeypox-Tied Run On Fresh $28 Million In Deals,https://www.investors.com/news/technology/siga-stock-extends-two-month-double-digit-run-on-new-monkeypox-deals/,https://bit.ly/3z8HFII
Investors,Why 'Covid Fatigue' Isn't Enough To Keep BioNTech Down; Shares Surge On Upgrade,https://www.investors.com/news/technology/bntx-stock-why-covid-fatigue-is-not-enough-to-keep-biontech-down/,https://bit.ly/3AR00eI
Investors,These Chipmakers Have The Least Risk For Order Cancellations,https://www.investors.com/news/technology/semiconductor-stocks-which-are-least-at-risk-for-order-cancellations/,https://bit.ly/3o4XwSl
Investors,Apellis Pharmaceuticals Stock Scores Relative Strength Rating Upgrade,https://www.investors.com/news/technology/apellis-pharmaceuticals-stock-scores-relative-strength-rating-upgrade/,https://bit.ly/3uSOewD
Investors,"Perrigo Stock Mystery; Big Money Loves It, Though Profits Slim",https://www.investors.com/news/technology/perrigo-earns-relative-strength-rating-upgrade/,https://bit.ly/3z7eqWT
Investors,"Amazon Prime Day Could Inspire Phishing Attacks, Ransomware",https://www.investors.com/news/technology/amazon-prime-day-spurs-phishing-attacks/,https://bit.ly/3IEUHAY
Investors,The Good News For Moderna's Covid Shot Wasn't Good News For Its Stock,https://www.investors.com/news/technology/moderna-stock-the-good-news-for-its-covid-booster-was-not-good-news-for-its-stock/,https://bit.ly/3aCXheb
Investors,"Could The Next CRISPR From Verve, Beam Signal The End To High Cholesterol?",https://www.investors.com/news/technology/verv-stock-the-next-crispr-is-here-with-verve-therapeutics-at-the-helm/,https://bit.ly/3AVh0Az
Investors,Will Novavax's Covid Booster Thesis Play Out? What The Survey Says,https://www.investors.com/news/technology/nvax-stock-will-its-covid-booster-thesis-play-out-or-flop/,https://bit.ly/3cl5G6M
Investors,ServiceNow Tumbles After CEO Says Sales Cycle In Europe Lengthening,https://www.investors.com/news/technology/now-stock-tumbles-as-servicenow-says-sales-cycle-in-europe-lengthening/,https://bit.ly/3P3VfTk
Investors,IPO Market Crumbles As It Gets Hammered By Multiple Issues,https://www.investors.com/news/technology/ipo-market-hammered-by-multiple-issues/,https://bit.ly/3AROCPL
Investors,"Uniqure Stock Sees Healthy Price Gain, Ranks Among Top 8%",https://www.investors.com/news/technology/stock-upgrades-uniqure-n-v-shows-rising-relative-strength-3/,https://bit.ly/3ANrAcL
Investors,Wall Street Rethinks Semiconductor Stocks Ahead Of Earnings,https://www.investors.com/news/technology/semiconductor-stocks-reevaluated-before-q2-earnings-season/,https://bit.ly/3IGDszf
Investors,"Meta Is Losing The Fight For Attention On Mobile Devices, Video",https://www.investors.com/news/technology/meta-stock-drops-on-downbeat-report/,https://bit.ly/3O6yWLK
Investors,Apple iPhone 14 To Face Weak Consumer Spending Environment,https://www.investors.com/news/technology/apple-stock-iphone-14-to-face-weak-consumer-spending/,https://bit.ly/3yzb5yb
Investors,Is The Sun Setting On The Glory Years For Facebook And Meta Stock?,https://www.investors.com/news/technology/meta-stock-sinks-sun-setting-facebook-mark-zuckerberg/,https://bit.ly/3z5YlAI
Investors,"Pharma Rally Continues As Pfizer, Amgen Look To Break Out, Pulling Rivals With Them",https://www.investors.com/news/technology/pharmaceutical-stocks-why-it-might-be-time-to-pay-attention-to-these-4-leaders/,https://bit.ly/3uPXVMq
Investors,Pliant Therapeutics Stock Just Doubled And Hit A 10-Month High — Here's Why,https://www.investors.com/news/technology/biotech-stock-pliant-doubles-and-hits-a-10-month-high-here-is-why/,https://bit.ly/3OXAfhh
Investors,Vir Biotechnology Stock Joins Rank Of Stocks With RS Ratings Over 90,https://www.investors.com/news/technology/vir-biotechnology-inc-joins-rank-of-stocks-with-rs-ratings-over-90/,https://bit.ly/3zgQ8dj
Investors,Twitter Stock Drops After Elon Musk Terminates Acquisition Plan,https://www.investors.com/news/technology/twitter-stock-acquisition-by-elon-musk-in-jeopardy/,https://bit.ly/3uOC7Rh
Investors,Taiwan Semiconductor Beats June-Quarter Sales Target,https://www.investors.com/news/technology/tsm-stock-taiwan-semiconductor-beats-june-quarter-sales-target/,https://bit.ly/3uPwBhi
Investors,"Google With Inside Track To Win Netflix Ad Partnership, Says Analyst",https://www.investors.com/news/technology/google-stock-with-inside-track-to-win-netflix-ad-partnership-analyst-says/,https://bit.ly/3IIAEBU
Investors,"Novavax, Moderna, BioNTech Surge To 3-Month High As Omicron Boosters Loom",https://www.investors.com/news/technology/vaccine-stocks-novavax-moderna-biontech-hit-fresh-highs-here-is-why/,https://bit.ly/3o64ab0
Investors,Kezar Life Sciences Stock Shows Rising Market Leadership: Earns 81 RS Rating,https://www.investors.com/news/technology/kezar-life-sciences-stock-shows-rising-market-leadership-earns-81-rs-rating/,https://bit.ly/3IIhfRC
Investors,"Apellis Pharmaceuticals Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/news/technology/apellis-pharmaceuticals-stock-clears-technical-benchmark-hitting-80-plus-rs-rating/,https://bit.ly/3ciXbZT
Investors,"Semiconductor Stocks Called Oversold, Rise After Samsung Report",https://www.investors.com/news/technology/semiconductor-stocks-called-oversold-rise-after-samsung-report/,https://bit.ly/3ARuo8Y
Investors,Merck Reportedly Eyes $40 Billion Seagen Tie-Up; Will The Deal Save Biotech?,https://www.investors.com/news/technology/sgen-stock-jumps-as-merck-reportedly-eyes-takeover/,https://bit.ly/3IoPlde
Investors,Biotechs Say ESG Is Core To Their Mission; Do Investors Believe Them?,https://www.investors.com/news/technology/esg-investing-will-biotechs-get-credit-for-saving-lives/,https://bit.ly/3o1S2rA
Investors,Chipmaker Impinj Stock Flashes Renewed Technical Strength,https://www.investors.com/news/technology/chipmaker-impinj-stock-flashing-renewed-technical-strength/,https://bit.ly/3nMDlZy
Investors,Tenable Holdings Stock Scores Rising Relative Strength Upgrade,https://www.investors.com/news/technology/tenable-holdings-stock-scores-shows-rising-relative-strength/,https://bit.ly/3ak1OSE
Investors,"Amazon Partners With Grubhub, Providing More Perks For Prime Members",https://www.investors.com/news/technology/amazon-stock-trades-flat-on-grubhub-announcement/,https://bit.ly/3uvrrGZ
Investors,Do You Have Biotech FOMO? It Might Be Time To Pay Attention To These Names,https://www.investors.com/news/technology/biotech-stocks-go-gangbusters-as-fomo-drives-a-3-week-double-digit-run/,https://bit.ly/3yMDd2i
Investors,Why Top-Notch Biotech Stock Vertex Pharmaceuticals Just Hit A Record,https://www.investors.com/news/technology/vrtx-stock-why-this-top-notch-biotech-leader-just-hit-a-fresh-high/,https://bit.ly/3o9FKxe
Investors,RingCentral Dives On Downgrade Amid Stiff Microsoft Competition,https://www.investors.com/news/technology/rng-stock-dives-on-downgrade-amid-stiff-microsoft-teams-competition/,https://bit.ly/3ARdyqv
Investors,Could Netflix Find A Merger Partner At Sun Valley Conference?,https://www.investors.com/news/technology/netflix-stock-is-video-streamer-a-takeover-target/,https://bit.ly/3o27Quz
Investors,Simulations Plus Stock Scores Composite Rating Move Up To 96,https://www.investors.com/news/technology/simulations-plus-stock-sees-composite-rating-move-up-to-96-2/,https://bit.ly/3aFJHa0
Investors,Pfizer Dives As CureVac Tees Up A Patent Suit Aimed At Its BioNTech-Partnered Covid Shot,https://www.investors.com/news/technology/pfizer-stock-crashes-into-50-day-line-as-curevac-squares-off-with-patent-suit/,https://bit.ly/3uPhIf3
Investors,"Palantir May Have 'Opportunity' In Facial Recognition Oversight, Says BofA",https://www.investors.com/news/technology/pltr-stock-may-have-opportunity-in-facial-recognition-oversight-says-bofa/,https://bit.ly/3AJ4FzB
Investors,Why IPO Stock Amylyx Pharmaceuticals Is Beginning To Heat Up — Again,https://www.investors.com/news/technology/ipo-stock-how-the-amylyx-yo-yo-keeps-swinging-on-als-treatment/,https://bit.ly/3P4Q7y1
Investors,"Apple Saving Big iPhone Updates For Next Year's Handset, Analyst Says",https://www.investors.com/news/technology/iphone-14-likely-minor-update-for-apple-smartphone/,https://bit.ly/3ICmMJn
Investors,Global Blood Therapeutic Stock Sees Relative Strength Rating Rise To 91,https://www.investors.com/news/technology/global-blood-therapeutic-stock-sees-relative-strength-rating-rise-to-91/,https://bit.ly/3NKU75L
Investors,Qualys Stock Joins Rank Of Stocks With RS Ratings Over 90,https://www.investors.com/news/technology/qualys-stock-joins-rank-of-stocks-with-rs-ratings-over-90-2/,https://bit.ly/3AZg9Pc
Investors,"Celldex Therapeutics Skids As It Takes On A Blockbuster Roche, Novartis Drug",https://www.investors.com/news/technology/cldx-stock-skids-as-it-takes-on-novartis-roche-blockbuster-drug/,https://bit.ly/3uOkIrI
Investors,Micron Stock Falls After Chipmaker Delivers Dismal Outlook,https://www.investors.com/news/technology/mu-stock-micron-delivers-dismal-outlook/,https://bit.ly/3AScLG6
Investors,"CDW Poised To Outpace Broader Information Technology Market, Analyst Says",https://www.investors.com/news/technology/cdw-stock-tech-services-firm-poised-to-outperform-it-market/,https://bit.ly/3OENSlh
Investors,Amazon Amps Up Its Prime Day And Plans Another During Fall,https://www.investors.com/news/technology/amazon-prime-day-coming-with-another-in-fall/,https://bit.ly/3AVh0R5
Investors,"Cross Country Stock Ran Up 575%, Among Best In Sector",https://www.investors.com/news/technology/cross-country-healthcare-earns-composite-rating-upgrade/,https://bit.ly/3z5H4HN
Investors,Sanofi Dives After FDA Slaps Its $3.7 Billion Drug With A Hold,https://www.investors.com/news/technology/sanofi-stock-crumbles-as-fda-slaps-a-drug-with-a-hold/,https://bit.ly/3IHdFa1
Investors,The FDA Just Handed BioNTech And Moderna A Gift — But Only One Jumped,https://www.investors.com/news/technology/bntx-stock-why-omicron-boosters-are-a-boon-for-biontech/,https://bit.ly/3aBptOQ
Investors,"Android Smartphone Makers Cutting Orders, But Apple Holds Firm",https://www.investors.com/news/technology/apple-stock-smartphone-makers-cutting-orders-but-not-apple/,https://bit.ly/3IEneGK
Investors,Amphastar Pharmaceuticals Stock Scores Composite Rating Climb To 96,https://www.investors.com/news/technology/amphastar-pharmaceutcls-stock-scores-composite-rating-climb-to-96/,https://bit.ly/3ciOPS0
Investors,Kura Oncology Stock Scores Rising Relative Strength,https://www.investors.com/news/technology/kura-oncology-stock-scores-rising-relative-strength/,https://bit.ly/3o2IpsD
Investors,Syndax Pharmaceuticals Stock Sees RS Rating Rise To 92,https://www.investors.com/news/technology/syndax-pharmaceuticals-stock-sees-rs-rating-rise-to-92/,https://bit.ly/3AVdbvc
Investors,Novavax Outperforms Rivals After FDA Panel Backs Updated Covid Shots,https://www.investors.com/news/technology/vaccine-stocks-tumble-as-fda-experts-mull-omicron-shots/,https://bit.ly/3oaCNMV
Investors,Chip Design Firms Upgraded As Chipmakers Downgraded,https://www.investors.com/news/technology/semiconductor-stocks-downgraded-chip-designers-upgraded/,https://bit.ly/3ARuopu
Investors,Why Corcept's Pill — And Stock — Is Getting Renewed Attention After Abortion Ruling,https://www.investors.com/news/technology/biotech-stock-why-corcept-not-abortion-pill-is-getting-renewed-attention/,https://bit.ly/3z94JYa
Investors,"Qualcomm Stock Rises As Apple's 5G Modem Chip 'Fails,' Analyst Says",https://www.investors.com/news/technology/qualcomm-stock-rises-as-apple-struggles-to-make-own-5g-chip/,https://bit.ly/3aAu0kB
Investors,"PC Market Chatter Roils Chip, Computer Makers",https://www.investors.com/news/technology/intel-stock-pc-market-chatter-roils-chip-computer-makers/,https://bit.ly/3noXvsg
